Hongkong
Antengene & MindRank AI to jointly develop first-in-class small-molecule oncology drugs
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commerc...
August 09, 2021 | News
eTheRNA immunotherapies opens office in Hong Kong to support and build on its growing activities in China and broader Asia-Pacific
The Asia-Pacific region is growing in importance in the global healthcare sector and this new subsidiary will serve as a focus for eTheRNA’s increasi...
August 03, 2021 | News
EC Healthcare, Prenetics to Pioneer the Future of Medicine
Under the collaboration, (i) EC Healthcare shall be the designated offline fulfillment partner of Prenetics online business; (ii) EC Healthcare shall ...
July 31, 2021 | News
Manulife Hong Kong to strengthen health solutions offering
Partnership provides Manulife customers with access to a new and advanced day medical centre and expanded smart healthcare services Manulife Hong Kong ann...
July 26, 2021 | News
PolyU develops biomedical monitoring capability
The Hong Kong Polytechnic University (PolyU) has made a breakthrough development in optical fibre sensors, making the advanced railway safety monitoring te...
July 06, 2021 | News
CARsgen Therapeutics officially listing on HKEX
CARsgen Therapeutics Holdings Limited (the "Company", stock code: 2171.HK) today announced that the Company's Shares have been traded on the Main Board of ...
June 19, 2021 | News
Antengene continued to execute its dual-engine growth strategy
Announces two new in-house discovered assets - ATG-031, a potential first-in-class anti-CD24 monoclonal antibody, and ATG-027, a potential first-in-class...
June 18, 2021 | News
Gilead Sciences committed to Global Elimination of Hepatitis C
Data Presented at the Global Hepatitis Summit Show that Virally Suppressed Patients from Taiwan with Renal or Hepatic Impairment had High Rates of Vi...
June 18, 2021 | News
The changing Hong Kong healthcare market
The launch of innovative drugs will drive growth in the market. Hong Kong is the leading choice for manufacturers of home-based equipment, hygiene-steriliz...
June 15, 2021 | News
Cigna Study Shows Uncertainty about the Future Continues to be the Leading Cause of Stress
Cigna Hong Kong today released the Hong Kong findings of the latest edition of its Cigna COVID-19 Global Impact Study. As part of Cigna's an...
June 08, 2021 | Analysis
Lifebit Awarded A Four-Year Contract for Hong Kong's Genome Project
The leader in precision medicine technology, Lifebit Biotech Ltd, today announced it has been awarded a four-year contract by Hong Kong Genome Institute (H...
May 26, 2021 | News
Most COVID-19 Patients Have Long-term Neurological Problems
In a surprise, however, a research team at NYU Grossman School of Medicine also found that 91 percent of patients, whether or not they had a neurological d...
May 25, 2021 | Analysis
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
